prof. dr. M.J. (Maarten) Postma
Professor Global Health Economics UMCG & RUG

Telephone:
E-mail:
m.j.postma rug.nl
Research
- 2014
- Ultsch, B., Damm, O., Beutels, P., Bilcke, J., Brüggenjürgen, B., Gerber-Grote, A. U., Greiner, W., Hanquet, G., Harder, T., Hutubessy, R., Jit, M., Knol, M., Kuhlmann, A., Von Kries, R., Levy-Bruhl, D., Perleth, M., Postma, M. J., Salo, H., Siebert, U., ... Postma, M. (2014). Methods for health economic evaluations of vaccines-results from an international expert-workshop. Value in Health, 17(7), 552. https://doi.org/10.1016/j.jval.2014.08.1803
- Pham, V. N. H., Hoang, T. M., & Postma, M. (2014). Pharmacoeconomic research and application in 10 Asian countries between 2003 and 2013: A systematic review. Value in Health, 17(7), 793. https://doi.org/10.1016/j.jval.2014.08.450
- Postma, M., Thavorncharoensap, M., Riewpaiboon, A., & Thinyounyong, W. (2014). Quality of life of diarrheal children and caregivers in Thailand rochanathimokeo. Value in Health, 17(7), A368-A369. https://doi.org/10.1016/j.jval.2014.08.832
- Treur, M., & Postma, M. (2014). Quasi-monte carlo simulation and variance reduction techniques substantially reduce computational requirements of patient-level simulation models: An application to a discrete event simulation model. Value in Health, 17(7), A326. https://doi.org/10.1016/j.jval.2014.08.585
- Crépey, P., De Boer, P., Postma, M. J., & Pitman, R. J. (2014). Retrospective public health impact of a quadrivalent influenza vaccine in the United States over the period 2000-2014. Value in Health, 17(7), 664-665. https://doi.org/10.1016/j.jval.2014.08.2446
- Schlander, M., Garattini, S., Holm, S., Kolominsky-Rabas, P. L., Nord, E., Persson, U., Postma, M. J., Richardson, J., Simoens, S., De Sola-Morales, O., Tolley, K., & Toumi, M. (2014). The evaluation of economic methods to assess the social value of medical interventions for ultra-rare disorders (URDs). Value in Health, 17(7), A324. https://doi.org/10.1016/j.jval.2014.08.570
- Stevanovic, J., Denee, L., Koenders, J. M., & Postma, M. J. (2014). Incidence description and costs of acute heart failure in the Netherlands. Value in Health, 17(7), A328-A328. https://doi.org/10.1016/j.jval.2014.08.597
- Nguyen, T-P-L., Nguyen, T. B. Y., Nguyen, T. T., Vinh Hac, V., Le, H. H., Schuiling-Veninga, N., & Postma, M. J. (2014). Direct costs of hypertensive patients admitted to hospital in Vietnam: a bottom-up micro-costing analysis. BMC Health Services Research, 14, [514]. https://doi.org/10.1186/s12913-014-0514-4
- van Boven, J. F. M., van Raaij, J. J., van der Galiën, R., Postma, M. J., van der Molen, T., Dekhuijzen, P. N. R., & Vegter, S. (2014). Impact of multiple-dose versus single-dose inhaler devices on COPD patients' persistence with long-acting beta(2)-agonists: A dispensing database analysis. npj Primary Care Respiratory Medicine, 24, [14069]. https://doi.org/10.1038/npjpcrm.2014.69
- De Vries, D., Denig, P., Vegter, S., Bos, H. J., Postma, M. J., & Hak, E. (2014). Does a cardiovascular event change adherence to statin treatment in patients with type 2 diabetes? A matched cohort design. Pharmacoepidemiology and Drug Safety, 23(S1), 319-320. https://doi.org/10.1002/pds.3701
- Standaert, B., Ethgen, O., Emerson, R., Postma, M., & Mauskopf, J. (2014). Comparing Cost-Effectiveness Results for a Vaccine Across Different Countries Worldwide: What Can We Learn? Advances in therapy, 31(10), 1095-1108. https://doi.org/10.1007/s12325-014-0160-6
- Van Boven, J., Tommelein, E., Mehuys, E., Boussery, K., Vegter, S., Brusselle, G., Rutten-Van Mölken, M., & Postma, M. (2014). Therapietrouwbevordering COPD bespaart kosten. Pharmaceutisch Weekblad, 149(39), 20-21.
- Bergmeijer, T. O., Janssen, P. W. A., Asselbergs, F. W., Schipper, J. C., Van 'T Hof, A. W., Dewilde, W. J. M., Postma, M. J., De Boer, A., Deneer, V. H. M., & Ten Berg, J. M. (2014). A tailored antiplatelet strategy in STEMI patients based on CYP2C19 genotyping is feasible in daily practice-POPular Genetics study. European Heart Journal, 35, 191-192. https://doi.org/10.1093/eurheartj/ehu323
- van Boven, J. F., Tommelein, E., Boussery, K., Mehuys, E., Vegter, S., Brusselle, G. G., Rutten-van Mölken, M. P., & Postma, M. J. (2014). Optimalisation de la pharmacothérapie en pharmacie d'officine chez des patients atteints de Bronchopneumopathie Chronique Obstructive (BPCO): une analyse coût-efficacité. Journal de Pharmacie de Belgique, (3), 15-16.
- Mafirakureva, N., Nyoni, H., Chikwereti, R., Khoza, S., Mvere, D. A., Emmanuel, J. C., Postma, M. J., & Van Hulst, M. (2014). The average unit production cost of blood in Zimbabwe from a provider's perspective. Transfusion, 54. https://doi.org/10.1111/trf.12845
- Vegter, S., Oosterhof, P., Van Boven, J. F. M., Stuurman-Bieze, A. G. G., Hiddink, E., & Postma, M. J. (2014). Therapietrouwbevordering lipidenverlagers is kosteneffectief: Kosteneffectiviteit bij primaire, kostenbesparing bij secundaire preventie. Pharmaceutisch Weekblad, 149(35), 30-31.
- Stevanovic, J., Pompen, M., Le, H. H., Rozenbaum, M. H., Tieleman, R. G., & Postma, M. J. (2014). Economic evaluation of apixaban for the prevention of stroke in non-valvular atrial fibrillation in the Netherlands. PLoS ONE, 9(8), [e103974]. https://doi.org/10.1371/journal.pone.0103974
- van Boven, J. F. M., Stuurman-Bieze, A. G. G., Hiddink, E. G., Postma, M. J., & Vegter, S. (2014). Medication monitoring and optimization: a targeted pharmacist program for effective and cost-effective improvement of chronic therapy adherence. Journal of Managed Care Pharmacy, 20(8), 786-792. http://www.ncbi.nlm.nih.gov/pubmed/25062071
- Schlander, M., Garattini, S., Holm, S., Kolominsky-Rabas, P., Nord, E., Persson, U., Postma, M., Richardson, J., Simoens, S., De Solà Morales, O., Tolley, K., & Toumi, M. (2014). Incremental cost per quality-adjusted life year gained? The need for alternative methods to evaluate medical interventions for ultra-rare disorders. Journal of Comparative Effectiveness Research, 3(4), 399-422. https://doi.org/10.2217/cer.14.34
- de Boer, P., Wilschut, J. C., & Postma, M. J. (2014). Cost-effectiveness of vaccination against herpes zoster. Human vaccines & immunotherapeutics, 10(7), 2048-2061. https://doi.org/10.4161/hv.28670
- Bergmeijer, T. O., Janssen, P. W. A., Schipper, J. C., Qaderdan, K., Ishak, M., Ruitenbeek, R. S., Asselbergs, F. W., van 't Hof, A. W. J., Dewilde, W. J. M., Spanó, F., Herrman, J-P. R., Kelder, J. C., Postma, M. J., de Boer, A., Deneer, V. H. M., & ten Berg, J. M. (2014). CYP2C19 genotype-guided antiplatelet therapy in ST-segment elevation myocardial infarction patients-Rationale and design of the Patient Outcome after primary PCI (POPular) Genetics study. American Heart Journal, 168(1), 16-22.e1. https://doi.org/10.1016/j.ahj.2014.03.006
- Le, H. H., Hodgkins, P., Postma, M. J., Kahle, J., Sikirica, V., Setyawan, J., Erder, M. H., & Doshi, J. A. (2014). Economic impact of childhood/adolescent ADHD in a European setting: the Netherlands as a reference case. European Child & Adolescent Psychiatry, 23(7), 587-598. https://doi.org/10.1007/s00787-013-0477-8
- Vegter, S., Oosterhof, P., van Boven, J. F. M., Stuurman-Bieze, A. G. G., Hiddink, E. G., & Postma, M. J. (2014). Improving adherence to lipid-lowering therapy in a community pharmacy intervention program: a cost-effectiveness analysis. Journal of Managed Care Pharmacy, 20(7), 722-732. https://doi.org/10.18553/jmcp.2014.20.7.722
- Suwantika, A. A., Beutels, P., & Postma, M. J. (2014). Cost-effectiveness of hepatitis A vaccination in Indonesia. Human vaccines & immunotherapeutics, 10(8), 2342-2349. https://doi.org/10.4161/hv.29353
- van Boven, J. F. M., Tommelein, E., Boussery, K., Mehuys, E., Vegter, S., Brusselle, G. G. O., Rutten-van Molken, M. P. M. H., & Postma, M. J. (2014). Improving inhaler adherence in patients with Chronic Obstructive Pulmonary Disease: A cost-effectiveness analysis. Respiratory Research, 15(1), [66]. https://doi.org/10.1186/1465-9921-15-66
- Pitman, J. P., Wilkinson, R. L., Basavaraju, S. V., Von Finckenstein, B. G., Smit Sibinga, C. T. H., Marfin, A., Postma, M. J., Mataranyika, M. N., & Tobias, J. L. (2014). Investments in blood safety improve the availability of blood to underserved areas in a sub-saharan african country. Vox Sanguinis, 107(Supplement S1 (57-248)), 70-71. https://doi.org/10.1111/vox.12155
- Radke, P. W., Halvorsen, S., Jukema, J. W., Kolh, P., Annemans, L., Postma, M. J., Ardissino, D., Kristensen, S. D., Bassand, J-P., Collet, J-P., Morais, J., Tuñón, J., & Halcox, J. (2014). Networks for improving care in patients with acute coronary syndrome: A framework. Acute Cardiac Care, 16(2), 41-48. https://doi.org/10.3109/17482941.2014.881502
- Connolly, M. P., Kuyvenhoven, J. P., Postma, M. J., & Nielsen, S. K. (2014). Cost and quality-adjusted life year differences in the treatment of active ulcerative colitis using once-daily 4 g or twice-daily 2g mesalazine dosing. Journal of Crohn's and Colitis, 8(5), 357-362. https://doi.org/10.1016/j.crohns.2013.09.015
- Van Boven, J. F., Tommelein, E., Boussery, K., Mehuys, E., Vegter, S., Brusselle, G. G., Rutten-Van Mölken, M. P. M. H., & Postma, M. J. (2014). Cost-effectiveness analysis of a pharmacist-led intervention on improving inhaler adherence in patients with chronic obstructive pulmonary disease. Value in Health, 17(3), A136. https://doi.org/10.1016/j.jval.2014.03.788
- Nguyen, T. P. L., Schuiling-Veninga, N., Nguyen, T. B. Y., Hang, V. T. T., Wright, E. P., & Postma, M. J. (2014). Models to Predict the Burden of Cardiovascular Disease Risk in a Rural Mountainous Region of Vietnam. Value in Health Regional Issues, 3(1), 87-93. https://doi.org/10.1016/j.vhri.2014.03.003
- Stevanovic, J., Pehlivanoglou, P., & Postma, M. J. (2014). Meta-analysis of preference-based quality of life values in heart failure. Value in Health, 17(3), A197-A197. https://doi.org/10.1016/j.jval.2014.03.1152
- De Cao, E., Melegaro, A., Klok, R., & Postma, M. (2014). Optimising assessments of the epidemiological impact in the Netherlands of paediatric immunisation with 13-valent pneumococcal conjugate vaccine using dynamic transmission modelling. PLoS ONE, 9(4), [e89415]. https://doi.org/10.1371/journal.pone.0089415
- Van Hasselt, F. M., Oud, M. J. T., Krabbe, P. F. M., Postma, M. J., & Loonen, A. J. M. (2014). Improving somatic health of outpatients with severe mental illness. Schizophrenia Research, 153(Supplement 1), S186-S187.
- Suwantika, A. A., Zakiyah, N., Lestari, K., & Postma, M. J. (2014). Accelerating the introduction of rotavirus immunization in Indonesia. Expert review of vaccines, 13(4), 463-472. https://doi.org/10.1586/14760584.2014.891940
- Parouty, M. B. Y., Le, H., Krooshof, D., & Postma, M. J. (2014). Differential time preferences for money and quality of life. Pharmacoeconomics, 32(4), 411-419. https://doi.org/10.1007/s40273-013-0124-8
- Stevanovic, J., O'Prinsen, A. C., Verheggen, B. G., Schuiling-Veninga, N., Postma, M. J., & Pechlivanoglou, P. (2014). Economic Evaluation of Primary Prevention of Cardiovascular Diseases in Mild Hypertension: A Scenario Analysis for the Netherlands. Clinical Therapeutics, 36(3), 368-384. https://doi.org/10.1016/j.clinthera.2014.01.008
- de Vries, F. M., Denig, P., Visser, S. T., Hak, E., & Postma, M. J. (2014). Cost-effectiveness of statins for primary prevention in patients newly diagnosed with type 2 diabetes in the Netherlands. Value in Health, 17(2), 223-230. https://doi.org/10.1016/j.jval.2013.12.010
- van Boven, J. F. M., Novak, A., Driessen, M. T., Boersma, C., Boomsma, M. M., & Postma, M. J. (2014). Economic Evaluation of Ropinirole Prolonged Release for Treatment of Parkinson’s Disease in The Netherlands. Drugs & Aging, 31(3), 193-201. https://doi.org/10.1007/s40266-013-0150-4
- Moolenaar, L. M., Connolly, M., Huisman, B., Postma, M. J., Hompes, P. G. A., van der Veen, F., & Mol, B. W. J. (2014). Costs and benefits of individuals conceived after IVF: a net tax evaluation in The Netherlands. Reproductive Biomedicine Online, 28(2), 239-245. https://doi.org/10.1016/j.rbmo.2013.10.002
- Mafirakureva, N., Khoza, S., Mvere, D. A., Chitiyo, M. E., Postma, M. J., & Van Hulst, M. (2014). Incidence and pattern of 12 years of reported transfusion adverse events in Zimbabwe: A retrospective analysis. Blood transfusion, 12(3), 362-367. https://doi.org/10.2450/2014.0156-13
- van Boven, J. F. M., Chavannes, N. H., van der Molen, T., Rutten-van Molken, M. P. M. H., Postma, M. J., & Vegter, S. (2014). Clinical and economic impact of non-adherence in COPD: A systematic review. Respiratory Medicine, 108(1), 103-113. https://doi.org/10.1016/j.rmed.2013.08.044
- Parouty, M. B. Y., & Postma, M. J. (2014). A probabilistic theory for intertemporal indifference. Theoretical Economics Letters, 4(6), 415-424. [46834]. https://doi.org/10.4236/tel.2014.46053
- Wouters, H., Quik, E. H., Boersma, F., Nygard, P., Bosman, J., Bottger, W. M., Mulder, H., Maring, J-G., Wijma-Vos, L., Beerden, T., van Doormaal, J., Postma, M. J., Zuidema, S. U., & Taxis, K. (2014). Discontinuing Inappropriate Medication in Nursing Home Residents (DIM-NHR Study): Protocol of a cluster randomised controlled trial. BMJ Open, 4(10), [e006082]. https://doi.org/10.1136/bmjopen-2014-006082
- Postma, M., & Boersma, C. (2014). Farmaco-economie. In HJ. Out, P. van Meurs, & R. van Olden (Eds.), Handboek farmaceutische geneeskunde (Vol. Hoofdstuk 7, pp. 99-118). Bohn, Stafleu, Van Loghum.
ID: 193217